Výsledky vyhledávání - "Naosuke Arima"

Autor: Yuhei, Kamada, Naosuke, Arima, Maiko, Hayashida, Daisuke, Nakamura, Makoto, Yoshimitsu, Kenji, Ishitsuka

Publikováno v: Leukemialymphoma. 63(7)

Mogamulizumab (Mog), an anti-C-C motif chemokine receptor 4 (CCR4) antibody, is a therapeutic for adult T-cell leukemia/lymphoma (ATL). Injuries of normal regulatory T cells (Tregs) which express CCR4 by Mog could result in immune-related adverse eve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ba4bab3414bf62488e64e15feb3b3318
https://pubmed.ncbi.nlm.nih.gov/35225126

Zobrazit plný text záznamu

[Adult T-cell leukemia-lymphoma with severe hepatic damage and fluid retention successfully treated with mogamulizumab]

Autor: Aya, Shodai, Hirosaka, Inoue, Yuhei, Kamada, Satoshi, Fujino, Tomohisa, Tabuchi, Naosuke, Arima, Yuichiro, Uchida, Miho, Hachiman, Daisuke, Nakamura, Makoto, Yoshimitsu, Kenji, Ishitsuka

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology. 61(6)

Adult T-cell leukemia-lymphoma (ATL) is a peripheral T-cell malignancy caused by the human T-cell lymphotropic virus, type I and it has an extremely poor prognosis. A 66-year-old man with severe hepatic damage, massive pleural effusion and ATL cell i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8ffd55fd31dc753cf911f895490ddffd
https://pubmed.ncbi.nlm.nih.gov/32624533

Zobrazit plný text záznamu

Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area

Autor: Naosuke Arima, Tadashi Matsumoto, Kenji Ishitsuka, Makoto Yoshimitsu, Hirosaka Inoue, Kakushi Matsushita, Daisuke Nakamura, Naomichi Arima, Maiko Hayashida, Tomohisa Tabuchi

Publikováno v: International journal of hematology. 111(2)

Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell neoplasm associated with the human T-cell leukemia virus type-I (HTLV-1); prognosis still remains very poor. We retrospectively reviewed the treatment of 198 patients with acute-, lymphoma-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d91aa91b6b688a01b26985a5a0519e
https://pubmed.ncbi.nlm.nih.gov/32144642

Zobrazit plný text záznamu

Essential thrombocytosis attributed to JAK2-T875N germline mutation

Autor: Kenji Ishitsuka, Yuichiro Uchida, Makoto Yoshimitsu, Kazuya Shimoda, Miho Hachiman, Masafumi Ito, Yuhei Kamada, Naosuke Arima, Kotaro Shide, Akihiko Arai

Publikováno v: International journal of hematology. 110(5)

The aim of this study was to elucidate the role of a non-canonical JAK2 mutation JAK2-T875N, which was identified by exome sequencing in a patient with essential thrombocytosis (ET) who had a family history of suspecting ET. Whole exome sequencing wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6be32c42abb86b7c4fdf335e4637e3e
https://pubmed.ncbi.nlm.nih.gov/31428969

Zobrazit plný text záznamu

[Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy]

Autor: Daisuke, Nakamura, Maiko, Hayashida, Kayoko, Kubota, Eiji, Matsuura, Tomohisa, Tabuchi, Naosuke, Arima, Hirosaka, Inoue, Makoto, Yoshimitsu, Kenji, Ishitsuka

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology. 59(5)

POEMS syndrome is often complicated by pulmonary hypertension. The standard therapy for patients with POEMS syndrome is high-dose chemotherapy followed by autologous stem cell transplantation. However, the safety of high-dose chemotherapy for patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db31564cb291764bba9c1d63269c1886
https://pubmed.ncbi.nlm.nih.gov/29877235

Zobrazit plný text záznamu

A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent

Autor: Ayako Kuroki, Miho Hachiman, Shinsuke Suzuki, Maiko Hayashida, Chibueze Chioma Ezinne, Satoshi Fujino, Makoto Yoshimitsu, Daisuke Nakamura, Yuhei Kamada, Hirosaka Inoue, Naomichi Arima, Heiichirou Hamada, Naosuke Arima, Tomohisa Tabuchi, Mamiko Arima, Akihiko Arai, Seiji Okada

Publikováno v: Experimental Hematology. 43:944-950

Adult T-cell leukemia/lymphoma (ATL) is caused by human T-lymphotrophic virus type 1 infection and is one of the most refractory malignant T-cell lymphomas. Improvement of ATL therapy options requires the establishment of appropriate ATL animal model

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07980a299557c65e4cd0545e9935c78f
https://doi.org/10.1016/j.exphem.2015.06.303

Zobrazit plný text záznamu

A Retrospective Analysis of Treatment Outcomes in Adult T Cell Leukemia/Lymphoma Patients with Aggressive Disease Treated with or without Allogeneic Stem Cell Transplantation: A Single-Center Experience

Autor: Hirosaka Inoue, Satoshi Fujino, Makoto Yoshimitsu, Daisuke Nakamura, Maiko Hayashida, Kenichi Maekawa, Heiichiro Hamda, Mamiko Arima, Naosuke Arima, Shinsuke Suzuki, Hideaki Kawada, Yuhei Kamada, Tomohisa Tabuchi, Kakushi Matsushita, Naomichi Arima, Akihiko Arai

Publikováno v: Biology of Blood and Marrow Transplantation. 21:696-700

Adult T cell leukemia/lymphoma (ATL) is an aggressive peripheral T cell neoplasm with very poor prognosis. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been reported as a curative treatment modality for ATL. However, there are n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a3944d437ebb21c0241161f2344e6d
https://doi.org/10.1016/j.bbmt.2014.12.020

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání